7-4790865-C-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_014855.3(AP5Z1):c.2131C>G(p.Arg711Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00144 in 1,605,730 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.2131C>G | p.Arg711Gly | missense_variant | Exon 16 of 17 | ENST00000649063.2 | NP_055670.1 | |
AP5Z1 | NM_001364858.1 | c.1663C>G | p.Arg555Gly | missense_variant | Exon 15 of 16 | NP_001351787.1 | ||
AP5Z1 | XM_047421098.1 | c.1795C>G | p.Arg599Gly | missense_variant | Exon 14 of 15 | XP_047277054.1 | ||
AP5Z1 | NR_157345.1 | n.2262C>G | non_coding_transcript_exon_variant | Exon 16 of 17 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152186Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000645 AC: 151AN: 234140Hom.: 0 AF XY: 0.000525 AC XY: 67AN XY: 127580
GnomAD4 exome AF: 0.00150 AC: 2173AN: 1453426Hom.: 1 Cov.: 32 AF XY: 0.00140 AC XY: 1013AN XY: 722138
GnomAD4 genome AF: 0.000919 AC: 140AN: 152304Hom.: 1 Cov.: 33 AF XY: 0.000725 AC XY: 54AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:5
- -
- -
- -
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Hereditary spastic paraplegia 48 Uncertain:3
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 711 of the AP5Z1 protein (p.Arg711Gly). This variant is present in population databases (rs113184057, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. ClinVar contains an entry for this variant (Variation ID: 478623). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Hereditary spastic paraplegia Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at